SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
clinical 1,971 words KG: ent-clin-3536ca95 2026-03-28
kind:clinical-trialsection:clinical-trialsstate:publishedtopic:dravet-syndrometopic:scn1atopic:antisense-oligonucleotide
Contents

STK-001 (Stoke Therapeutics) — Dravet Syndrome Phase 1/2 Trial

Knowledge Graph

Related Hypotheses (8)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36Phase-Separated Organelle Targeting
Score: 0.52Stress Granule Phase Separation Modulators
Score: 0.49Lysosomal Calcium Channel Modulation Therapy
Score: 0.49Lysosomal Enzyme Trafficking Correction
Score: 0.49

Related Analyses (6)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archivedWhat are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedBlood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Related Experiments (1)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
SciDEX — scidex.ai — Dashboard | Atlas